Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing (2021)
- Authors:
- Mendrone Junior, Alfredo

- Dinardo, Carla Luana

- Ferreira, Suzete Cleuza

- Nishya, Anna

- Salles, Nanci Alves
- Almeida Neto, Cesar de

- Hamasaki, Debora Toshei
- Facincani, Tila

- Alves, Lucas Bassolli de Oliveira

- Machado, Rafael Rahal Guaragna

- Araujo, Danielle Bastos

- Durigon, Edison Luiz

- Rocha, Vanderson Geraldo

- Sabino, Ester Cerdeira

- Mendrone Junior, Alfredo
- USP affiliated authors: DURIGON, EDISON LUIZ - ICB ; ROCHA, VANDERSON GERALDO - FM ; SABINO, ESTER CERDEIRA - FM ; MACHADO, RAFAEL RAHAL GUARAGNA - ICB
- Unidades: ICB; FM
- DOI: 10.1111/trf.16268
- Subjects: MICROBIOLOGIA; COVID-19; IMUNOENSAIO; IMUNOGLOBULINAS; ANTICORPOS; TESTES IMUNOLÓGICOS; PLASMA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Transfusion
- ISSN: 1537-2995
- Volume/Número/Paginação/Ano: 10 p., 2021
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
MENDRONE JUNIOR, Alfredo et al. Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing. Transfusion, p. 10 , 2021Tradução . . Disponível em: https://doi.org/10.1111/trf.16268. Acesso em: 20 jan. 2026. -
APA
Mendrone Junior, A., Dinardo, C. L., Ferreira, S. C., Nishya, A., Salles, N. A., Almeida Neto, C. de, et al. (2021). Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing. Transfusion, 10 . doi:10.1111/trf.16268 -
NLM
Mendrone Junior A, Dinardo CL, Ferreira SC, Nishya A, Salles NA, Almeida Neto C de, Hamasaki DT, Facincani T, Alves LB de O, Machado RRG, Araujo DB, Durigon EL, Rocha VG, Sabino EC. Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing [Internet]. Transfusion. 2021 ;10 .[citado 2026 jan. 20 ] Available from: https://doi.org/10.1111/trf.16268 -
Vancouver
Mendrone Junior A, Dinardo CL, Ferreira SC, Nishya A, Salles NA, Almeida Neto C de, Hamasaki DT, Facincani T, Alves LB de O, Machado RRG, Araujo DB, Durigon EL, Rocha VG, Sabino EC. Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing [Internet]. Transfusion. 2021 ;10 .[citado 2026 jan. 20 ] Available from: https://doi.org/10.1111/trf.16268 - Cross-lineage protection between chikv primary infection and mayv secondary exposure in mice
- Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial
- Identification and Characterization of Hematopoietic Stem Cell Transplant Candidates in a Sickle Cell Disease Cohort
- Is Severity Score Associated With Indication for Hematopoietic Stem Cell Transplantation in Individuals With Sickle Cell Anemia?
- Anti‐A and SARS‐CoV‐2: an intriguing association
- Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): how useful could they be?
- Nebulized enriched heparin improves respiratory parameters in patients with COVID-19: a phase I/II randomized and triple-blind clinical trial
- Nebulized enriched heparin to treat no critical patients with Sars-Cov-2: triple-blind clinical trial
- A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections
- Effectiveness of strategies to screen for blood donors with RH variants in a mixed population
Informações sobre o DOI: 10.1111/trf.16268 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
